Sign inJoin waitlistJoin the waitlist

Suma Babu

Co-Director, Neurological Clinical Research Institute · Mass General Brigham

Credentials: · · · · · ·

History

Neurological Clinical Research Institute Center · Mass General Brigham
Present
NEALS neuroimaging subcommittee Department
Present
Harvard Medical School
Present

Massachusetts General Hospital
2016–2017
Neuromuscular Medicine
Brigham and Women's Hospital
2015–2016
Neurology
Cleveland Clinic
2013–2015
Child Neurology
Cleveland Clinic Foundation
2010–2013
Cleveland Clinic
2009–2010
Bangalore Medical College University
2003
Bangalore Medical College University
2002–2003

Research

Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
New England Journal of Medicine · 2022 · 755 citations
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
New England Journal of Medicine · 2020 · 415 citations
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis
Muscle & Nerve · 2021 · 141 citations

Sabrina Paganoni
32 papers
James Berry
25 papers
Merit Cudkowicz
24 papers
NA
Nazem Atassi
14 papers
Jeremy Shefner
13 papers
Shafeeq Ladha
13 papers
Timothy Miller
13 papers
Jonathan Glass
11 papers
Michael Benatar
11 papers
Andrea Swenson
10 papers
DH
Daragh Heitzman
10 papers
JK
Jonathan Katz
10 papers

Grants

Access for All in ALS (ALL ALS) East Clinical Coordinating Center
National Institute of Neurological Disorders and Stroke · OT2
PI · $71.5M · Massachusetts General Hospital
2023–2028
An Intermediate-Size Expanded Access Protocol for Amyotrophic Lateral Sclerosis with Pridopidine
National Institute of Neurological Disorders and Stroke · U01
PI · $29.6M · Massachusetts General Hospital
2023–2027
Intermediate-Size Expanded Access Trial of Autologous Hybrid TREG/Th2 Cell Therapy (RAPA-501) of Amyotrophic Lateral Sclerosis
National Institute of Neurological Disorders and Stroke · U01
PI · $33M · Massachusetts General Hospital
2023–2027
An Expanded Access Protocol of Intravenous Trehalose Injection 90 Mg/mL Treatment of Patients with Amyotrophic Lateral Sclerosis
National Institute of Neurological Disorders and Stroke · UF1
PI · $18.1M · Massachusetts General Hospital
2022–2026

Clinical trials

Do Video Recordings of Multidisciplinary Clinics Improve Quality of Life for People With ALS and Their Caregivers?
Principal investigator · Not yet recruiting
Trustees of Dartmouth College
2026–2029
Study of Safety, Tolerability, and Biological Activity of LAM-002A in C9ORF72-Associated Amyotrophic Lateral Sclerosis
Principal investigator · Completed · Phase 2
OrphAI Therapeutics
2021–2025
A Biomarker Study to Evaluate MN-166 in Subjects With Amyotrophic Literal Sclerosis (ALS)
Principal investigator · Completed · Phase 1, Phase 2
MediciNova
2016–2020
Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Principal investigator · Completed
Massachusetts General Hospital
2015–2019